Acrivon Therapeutics | EFFECT: Others
Apr 30 06:11 ET
Acrivon Therapeutics | ARS: Annual Report to Security Holders
Apr 26 08:38 ET
Acrivon Therapeutics | DEFA14A: Others
Apr 26 08:38 ET
Acrivon Therapeutics | DEF 14A: Definitive information statements
Apr 26 08:33 ET
Acrivon Therapeutics | 8-K: Current report
Apr 24 16:06 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary
Apr 19 16:15 ET
Acrivon Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Apr 17 16:41 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Apr 15 16:20 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner PERCEPTIVE ADVISORS LLC
Apr 15 08:58 ET
Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%), etc.
Apr 15 08:23 ET
Acrivon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%), etc.
Apr 11 16:22 ET
Acrivon Therapeutics | 8-K: Current report
Apr 9 07:09 ET
Acrivon Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 29 09:07 ET
Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Mar 28 08:04 ET
Acrivon Therapeutics | 10-K: Annual report
Mar 28 07:39 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Mar 6 16:36 ET
Acrivon Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Palani Santhosh
Mar 6 16:31 ET
Acrivon Therapeutics | 8-K: Current report
Mar 4 08:20 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Masson Kristina
Feb 16 17:19 ET
Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary
Feb 16 17:18 ET
No Data
No Data